Novo Research Suggests GLP-1 Induced Muscle Loss May Not Be Such A Big Problem

 
• By Andrew McConaghie
  
The fast evolving science of GLP-1 agonists and next generation obesity therapies dominated the EASD congress once again. (EASD – European Association for the Study of Diabetes)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D